Acute myeloid leukaemia+3
RecruitingTitle: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727
Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727
- Disease:Acute myeloid leukaemiaChronic myelomonocytic leukaemia+2
- Substances:CedazuridineDecitabine
Slovakia- Participants:18–64 years · 65+ years
- Substances:Cedazuridine
- Sponsor:Taiho Oncology Inc.



